The role of cytosolic phospholipase A2α in amyloid precursor protein induction by amyloid beta1-42: Implication for neurodegeneration

Journal of Neurochemistry

Volumn 132, Issue 5, 2015, Pages 559-571

  Sagy Bross, Chen ^a   Kasianov, Ksenia ^a   Solomonov, Yulia ^a   Braiman, Alex ^a   Friedman, Alon ^a   Hadad, Nurit ^a   Levy, Rachel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

APP; cortical neurons; cytosolic phospholipase A2

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2ALPHA; ESTERASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROSTAGLANDIN E2; SERINE; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; PHOSPHOLIPASE A2 GROUP IV;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMALE; MALE; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ALZHEIMER DISEASE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; GEL MOBILITY SHIFT ASSAY; HUMAN; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

MUS; RATTUS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GROUP IV PHOSPHOLIPASES A2; HUMANS; MALE; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NEURONS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84938739897     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13012     Document Type: Article

References (52)

1. Barnham K. J., Masters C. L., and, Bush A. I., (2004) Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3, 205-214.
2. Bosetti F., and, Weerasinghe G. R., (2003) The expression of brain cyclooxygenase-2 is down-regulated in the cytosolic phospholipase A2 knockout mouse. J. Neurochem. 87, 1471-1477.
3. Card J. P., Meade R. P., and, Davis L. G., (1988) Immunocytochemical localization of the precursor protein for beta-amyloid in the rat central nervous system. Neuron 1, 835-846.
4. Chu J., and, Pratico D., (2011) 5-lipoxygenase as an endogenous modulator of amyloid beta formation in vivo. Ann. Neurol. 69, 34-46.
5. Clark J. D., Milona N., and, Knopf J. L., (1990) Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. Proc. Natl Acad. Sci. USA 87, 7708-7712.
6. Clemens J. A., Stephenson D. T., Smalstig E. B., Roberts E. F., Johnstone E. M., Sharp J. D., Little S. P., and, Kramer R. M., (1996) Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat [see comments]. Stroke 27, 527-535 issn: 0039-2499.
7. Cohen M. L., Golde T. E., Usiak M. F., Younkin L. H., and, Younkin S. G., (1988) In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease. Proc. Natl Acad. Sci. USA 85, 1227-1231.
8. Colangelo V., Schurr J., Ball M. J., Pelaez R. P., Bazan N. G., and, Lukiw W. J., (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70, 462-473.
9. Craft J. M., Van Eldik L. J., Zasadzki M., Hu W., and, Watterson D. M., (2004a) Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human beta-amyloid in a murine model of neuroinflammation. J. Mol. Neurosci. 24, 115-122.
10. Craft J. M., Watterson D. M., Frautschy S. A., and, Van Eldik L. J., (2004b) Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo. Neurobiol. Aging 25, 1283-1292.
11. Craft J. M., Watterson D. M., and, Van Eldik L. J., (2006) Human amyloid beta-induced neuroinflammation is an early event in neurodegeneration. Glia 53, 484-490.
12. Dahlgren K., Manelli A., Blaine Stine Jr. S., Baker L., Krafft G., and, LaDu M., (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277, 32046-32053.
13. Desbene C., Malaplate-Armand C., Youssef I., et al,. (2012) Critical role of cPLA2 in Abeta oligomer-induced neurodegeneration and memory deficit. Neurobiol. Aging 33, 1123. e1117-e1129.
14. Frautschy S. A., Yang F., Calderon L., and, Cole G. M., (1996) Rodent models of Alzheimer's disease: rat A beta infusion approaches to amyloid deposits. Neurobiol. Aging 17, 311-321.
15. Frautschy S. A., Hu W., Kim P., Miller S. A., Chu T., Harris-White M. E., and, Cole G. M., (2001) Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol. Aging 22, 993-1005.
16. Haass C., Hung A. Y., Schlossmacher M. G., Oltersdorf T., Teplow D. B., and, Selkoe D. J., (1993) Normal cellular processing of the beta-amyloid precursor protein results in the secretion of the amyloid beta peptide and related molecules. Ann. N. Y. Acad. Sci. 695, 109-116.
17. Hadad N., Tuval L., Elgazar-Carmom V., Levy R., and, Levy R., (2011) Endothelial ICAM-1 protein induction is regulated by cytosolic phospholipase A2alpha via both NF-kappaB and CREB transcription factors. J. Immunol. 186, 1816-1827.
18. Hazan-Eitan Z., Weinstein Y., Hadad N., Konforty A., and, Levy R., (2006) Induction of Fc gammaRIIA expression in myeloid PLB cells during differentiation depends on cytosolic phospholipase A2 activity and is regulated via activation of CREB by PGE2. Blood 108, 1758-1766.
19. He Y., Cui J., Lee J., et al,. (2011) Prolonged exposure of cortical neurons to oligomeric amyloid-beta impairs NMDA receptor function via NADPH oxidase-mediated ROS production: protective effect of green tea (-)-epigallocatechin-3-gallate. ASN Neuro 3, 13e-24e.
20. Heinemeyer T., Wingender E., Reuter I., et al,. (1998) Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26, 362-367.
21. Higgins G. A., Lewis D. A., Bahmanyar S., Goldgaber D., Gajdusek D. C., Young W. G., Morrison J. H., and, Wilson M. C., (1988) Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc. Natl Acad. Sci. USA 85, 1297-1301.
22. Hoshino T., Nakaya T., Homan T., et al,. (2007) Involvement of prostaglandin E2 in production of amyloid-beta peptides both in vitro and in vivo. J. Biol. Chem. 282, 32676-32688.
23. Kartvelishvily E., Shleper M., Balan L., Dumin E., and, Wolosker H., (2006) Neuron-derived D-serine release provides a novel means to activate N-methyl-D-aspartate receptors. J. Biol. Chem. 281, 14151-14162.
24. Kawarabayashi T., Shoji M., Harigaya Y., Yamaguchi H., and, Hirai S., (1991) Expression of APP in the early stage of brain damage. Brain Res. 563, 334-338.
25. Koo E. H., Sisodia S. S., Archer D. R., Martin L. J., Weidemann A., Beyreuther K., Fischer P., Masters C. L., and, Price D. L., (1990) Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc. Natl Acad. Sci. USA 87, 1561-1565.
26. Kramer R. M., and, Pepinsky R. B., (1991) Assay and purification of phospholipase A2 from human synovial fluid in rheumatoid arthritis. Methods Enzymol. 197, 373-381.
27. Kriem B., Sponne I., Fifre A., et al,. (2005) Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide. FASEB J. 19, 85-87.
28. Lee V. M., and, Trojanowski J. Q., (1999) Neurodegenerative tauopathies: human disease and transgenic mouse models. Neuron 24, 507-510.
29. Liberty I., Raichel L., Hazan-Eitan Z., Pessach I., Hadad N., Schlaeffer F., and, Levy R., (2004) Cytosolic phospholipase A2 is responsible for prostaglandin E2 and leukotriene B4 formation in phagocyte-like PLB-985 cells: studies of differentiated cPLA2-deficient PLB-985 cells. J. Leukoc. Biol. 76, 176-184.
30. Ma Q. L., Harris-White M. E., Ubeda O. J., Simmons M., Beech W., Lim G. P., Teter B., Frautschy S. A., and, Cole G. M., (2007) Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models. J. Neurochem. 103, 1594-1607.
31. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., and, Cotman C. W., (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
32. Pooler A. M., Arjona A. A., Lee R. K., and, Wurtman R. J., (2004) Prostaglandin E2 regulates amyloid precursor protein expression via the EP2 receptor in cultured rat microglia. Neurosci. Lett. 362, 127-130.
33. Pugazhenthi S., Wang M., Pham S., Sze C. I., and, Eckman C. B., (2011) Downregulation of CREB expression in Alzheimer's brain and in Abeta-treated rat hippocampal neurons. Mol. Neurodegener. 6, 60.
34. Qin W., Ho L., Pompl P., et al,. (2003) Cyclooxygenase (COX)-2 and COX-1 potentiate beta-amyloid peptide generation through mechanisms that involve gamma-secretase activity. J. Biol. Chem. 278, 50970-50977.
35. Raichel L., Berger S., Hadad N., Kachko L., Karter M., Szaingurten-Solodkin I., Williams R. O., Feldmann M., and, Levy R., (2008) Reduction of cPLA2alpha overexpression: an efficient anti-inflammatory therapy for collagen-induced arthritis. Eur. J. Immunol. 38, 2905-2915.
36. Ralay Ranaivo H., Craft J. M., Hu W., Guo L., Wing L. K., Van Eldik L. J., and, Watterson D. M., (2006) Glia as a therapeutic target: selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration. J. Neurosci. 26, 662-670.
37. Sagy-Bross C., Hadad N., and, Levy R., (2013) Cytosolic phospholipase aalpha upregulation mediates apoptotic neuronal death induced by aggregated amyloid-beta peptide. Neurochem. Int. 63, 541-550.
38. Salbaum J. M., Weidemann A., Lemaire H. G., Masters C. L., and, Beyreuther K., (1988) The promoter of Alzheimer's disease amyloid A4 precursor gene. EMBO J. 7, 2807-2813.
39. Sanchez-Mejia R., Newman J., Toh S., et al,. (2008) Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat. Neurosci. 11, 1311-1318.
40. Schettini G., Govoni S., Racchi M., and, Rodriguez G., (2010) Phosphorylation of APP-CTF-AICD domains and interaction with adaptor proteins: signal transduction and/or transcriptional role-relevance for Alzheimer pathology. J. Neurochem. 115, 1299-1308.
41. Shelat P., Chalimoniuk M., Wang J., Strosznajder J., Lee J., Sun A., Simonyi A., and, Sun G., (2008) Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J. Neurochem. 106, 45-55.
42. Shoji M., Hirai S., Yamaguchi H., Harigaya Y., and, Kawarabayashi T., (1990) Amyloid beta-protein precursor accumulates in dystrophic neurites of senile plaques in Alzheimer-type dementia. Brain Res. 512, 164-168.
43. Stephenson D. T., Lemere C. A., Selkoe D. J., and, Clemens J. A., (1996) Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol. Dis. 3, 51-63.
44. Stephenson D., Rash K., Smalstig B., et al,. (1999) Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration. Glia 27, 110-128.
45. Sun G. Y., Chuang D. Y., Zong Y., Jiang J., Lee J. C., Gu Z., and, Simonyi A., (2014) Role of cytosolic phospholipase A in oxidative and inflammatory signaling pathways in different cell types in the central nervous system. Mol. Neurobiol. 50, 6-14.
46. Szaingurten-Solodkin I., Hadad N., and, Levy R., (2009) Regulatory role of cytosolic phospholipase A2alpha in NADPH oxidase activity and in inducible nitric oxide synthase induction by aggregated Abeta1-42 in microglia. Glia 57, 1727-1740.
47. Thinakaran G., and, Koo E. H., (2008) Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem. 283, 29615-29619.
48. Vitolo O. V., Sant'Angelo A., Costanzo V., Battaglia F., Arancio O., and, Shelanski M., (2002) Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl Acad. Sci. USA 99, 13217-13221.
49. Xiang Z., Ho L., Yemul S., et al,. (2002) Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimer's disease neuropathology. Gene Expr. 10, 271-278.
50. Yamamoto-Sasaki M., Ozawa H., Saito T., Rosler M., and, Riederer P., (1999) Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res. 824, 300-303.
51. Zhang Y. W., Thompson R., Zhang H., and, Xu H., (2011) APP processing in Alzheimer's disease. Mol. Brain 4, 3.
52. Zhang Y. W., Thompson R., Zhang H., and, Xu H., (2011) APP processing in Alzheimer's disease. Mol. Brain 4, 3.